TCRX

TSCAN THERAPEUTICS INC

TCRX·89854M101·US·Common Stock·Healthcare - Biotechnology-13D/G

TCRX (TSCAN THERAPEUTICS INC) is held by 44 institutional investors as of Q1 2026. Largest holders: BAKER BROS. ADVISORS LP ($2.8M), VANGUARD CAPITAL MANAGEMENT LLC ($2.2M), BlackRock, Inc. ($1.9M). Net institutional sentiment: Mixed.

44
Holders
Avg rating(12 Elite)
$16.2M
Total Value
47% (49)
Fund Consensus
20 buying - 23 selling
TCRXSmart Money Verdict
View all
Held by 44 funds
12 elite
Who's Trading
ActivistBLBVF PARTNERS L P/IL10.0%May 15, 2026
InsiderLLLynx1 Capital Management LPBuy $6KDec 23, 2025
InsiderLLLynx1 Capital Management LPBuy $68KDec 22, 2025
InsiderLLLynx1 Capital Management LPBuy $72KDec 19, 2025
ActivistLYLynx1 Capital Management LP15.0%Aug 14, 2025
ActivistADAdage Capital Management, L.P.2.5%Aug 12, 2025
ActivistBlackRock, Inc.BlackRock, Inc.1.8%Jul 16, 2025
InsiderLLLynx1 Capital Management LPBuy $1.4MMay 20, 2025
InsiderLLLynx1 Capital Management LPBuy $1.7MMay 19, 2025
ActivistECEcoR1 Capital, LLC1.3%May 15, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
2.8M$2.8M0.0%-81.55%
0
New
2.2M$2.2M0.0%+5.83%
36
Decreased
1.8M(-0.4%)$1.9M0.0%-63.67%
0
Increased
1.5M(+261.8%)$1.5M0.0%-3.30%
41
Increased
1.4M(+19.6%)$1.4M0.0%-15.67%
30
Increased
1.2M(+85.7%)$1.2M0.0%-6.83%
39
Decreased
918,020(-48.6%)$927,2000.0%-60.30%
0
Increased
808,356(+329.6%)$816,4400.0%+5.83%
40
Increased
616,952(+9.8%)$623,3400.0%-75.36%
18
Increased
319,587(+360.3%)$322,7830.0%+5.83%
38
Increased
318,411(+95.5%)$321,5960.0%-22.67%
38
New
305,772$308,8300.0%+5.83%
32
Decreased
237,346(-30.0%)$239,7190.0%+0.84%
0
Unchanged
207,313$209,3860.0%-79.90%
0
Decreased
173,643(-23.1%)$175,3790.0%-64.93%
0
Decreased
157,228(-27.3%)$158,8000.0%-17.57%
0
Decreased
144,421(-62.8%)$145,8650.0%-1.58%
0
Unchanged
143,051$144,4820.0%-80.07%
0
Decreased
97,448(-0.8%)$98,4220.0%-75.67%
0
Unchanged
91,463$92,3780.0%-29.68%
0

Showing 1-20 of 49

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used